Recent Finacing
Recent Raise
Revitope Oncology develops APEC immunotherapy platform that uses tumor-targeting antibodies to deliver viral antigens to tumors, enabling virus-specific T cells to recognize and kill solid and hematologic cancers.
Focus Areas
Total Raised
Funding round